Antiproliferative and apoptosis-inducing effects of lipophilic vitamins on human melanoma A375 cells in vitro

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 1, 2012, Pages 10-17

  Ishibashi, Mai ^a   Arai, Mariko ^b   Tanaka, Sachiko ^a   Onda, Kenji ^a   Hirano, Toshihiko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

A375 human melanoma cell; Apoptosis; Caspase 3; Growth inhibition; Lipophilic vitamin

Indexed keywords

4 AMINO 2 METHYL 1 NAPHTHOL; ALPHA TOCOPHEROL; CASPASE 3; COLECALCIFEROL; DACARBAZINE; MENADIONE; PHYTOMENADIONE; RETINOIC ACID; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN A375; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INHIBITION KINETICS; MELANOMA CELL;

ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLECALCIFEROL; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INHIBITORY CONCENTRATION 50; MELANOMA; TRETINOIN; VITAMIN K; VITAMINS;

EID: 84855690013     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.10     Document Type: Article

References (26)

1. Serrone L, Zeuli M, Sega FM, Cognetti F. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. J. Exp. Clin. Cancer Res., 19, 21-34 (2000).
2. Rubin KM, Lawrence DP. Your patient with melanoma: staging, prognosis, and treatment. Oncology (Huntington), 23 (Suppl.), 13-21 (2009).
3. Degos L. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy. Int. J. Cell Cloning, 10, 63-69 (1992).
4. Frampton RJ, Omond SA, Eisman JA. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res., 43, 4443-4447 (1983).
5. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet, I, 188-191 (1989).
6. Welsh J. Vitamin D and prevention of breast cancer. Acta Pharmacol. Sin., 28, 1373-1382 (2007).
7. Kanai K, Kikuchi E, Mikami S, Suzuki E, Uchida Y, Kodaira K, Miyajima A, Ohigashi T, Nakashima J, Oya M. Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo. Cancer Sci., 101, 216-223 (2010).
8. Kuriyama S, Hitomi M, Yoshiji H, Nonomura T, Tsujimoto T, Mitoro A, Akahane T, Ogawa M, Nakai S, Deguchi A, Masaki T, Uchida N. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Int. J. Oncol., 27, 505-511 (2005).
9. Zhang H, Satyamoorthy K, Herlyn M, Rosdahl I. All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells - a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution. Carcinogenesis, 24, 185-191 (2003).
10. Reichrath J, Rech M, Moeini M, Meese E, Tilgen W, Seifert M. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol. Ther., 6, 48-55 (2007).
11. Prasad KN, Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res., 42, 550-555 (1982).
12. Henmi K, Hiwatashi Y, Hikita E, Toyama N, Hirano T. Methoxyand fluoro-chalcone derivatives arrest cell cycle progression and induce apoptosis in human melanoma cell A375. Biol. Pharm. Bull., 32, 1109-1113 (2009).
13. Ishii K, Tanaka S, Kagami K, Henmi K, Toyoda H, Kaise T, Hirano T. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. Cancer Invest., 28, 220-229 (2010).
14. Masuda M, Tanaka S, Nakajima K, Yamada N, Ido N, Ohtsuka T, Nishida M, Hirano T, Utsumi H. Clinical implications of the type 1/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients. Eur. J. Pharmacol., 627, 325-331 (2010).
15. Fok JY, Ekmekcioglu S, Mehta K. Implications of tissue transglutaminase expression in malignant melanoma. Mol. Cancer Ther., 5, 1493-1503 (2006).
16. Turley JM, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation. Nutr. Cancer, 18, 201-213 (1992).
17. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest. Nutr. Cancer, 27, 92-101 (1997).
18. Kommagani R, Whitlatch A, Leonard MK, Kadakia MP. p73 is essential for vitamin D-mediated osteoblastic differentiation. Cell Death Differ., 17, 398-407 (2010).
19. Ogawa M, Nakai S, Deguchi A, Nonomura T, Masaki T, Uchida N, Yoshiji H, Kuriyama S. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Int. J. Oncol., 31, 323-331 (2007).
20. Akiyoshi T, Matzno S, Sakai M, Okamura N, Matsuyama K. The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway. Cancer Chemother. Pharmacol., 65, 143-150 (2009).
21. Nishimaki J, Miyazawa K, Yaguchi M, Katagiri T, Kawanishi Y, Toyama K, Ohyashiki K, Hashimoto S, Nakaya K, Takiguchi T. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation. Leukemia, 13, 1399-1405 (1999).
22. Shah M, Stebbins JL, Dewing A, Qi J, Pellecchia M, Ronai ZA. Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis. Pigment Cell Melanoma Res., 22, 799-808 (2009).
23. Chowdhury R, Chowdhury S, Roychoudhury P, Mandal C, Chaudhuri K. Arsenic induced apoptosis in malignant melanoma cells is enhanced by menadione through ROS generation, p38 signaling and p53 activation. Apoptosis, 14, 108-123 (2009).
24. Park BK, Scott AK, Wilson AC, Haynes BP, Breckenridge AM. Plasma disposition of vitamin K1 in relation to anticoagulant poisoning. Br. J. Clin. Pharmacol., 18, 655-662 (1984).
25. Soedirman JR, De Bruijn EA, Maes RAA, Hanck A, Grüter J. Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation. Br. J. Clin. Pharmacol., 41, 517-523 (1996).
26. Marchesi F, Turriziani M, Tortorelli G, Avvisati G, Torino F, De Vecchis L. Triazene compounds: mechanism of action and related DNA repair systems. Pharmacol. Res., 56, 275-287 (2007).